Data from a First-in-Human feasibility trial to treat glaucoma demonstrated a 45% drop in mean intraocular pressure at 3 months. SpyGlass Pharma presented.
SpyGlass Pharma Appoints Industry Veteran Patrick Mooney as Chief Executive Officer prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
In Advanced Glaucoma, Trabeculectomy Lowers IOP More Than Medication medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.